Sunday, February 26, 2017
To Be At All Useful The New Digital Health Strategy Needs Exceptional Forward Technology Insight.
On the basis of a comment made on the blog I followed up on this 1 hour YouTube presentation during the week. It really was more than worthwhile to do so!
Uploaded on Feb 14, 2017
It was a pleasure to welcome Professor John Mattick to our Agency today to deliver our first Grand Rounds: Lunch and Learn seminar. Professor Mattick is one of Australia’s leading lights in Health and Medical Research and internationally renowned for his pioneering work in the field of genomics. He takes us on a fascinating journey of genomics, and the possibilities that are being unlocked in our new era of precision medicine. His talk challenges us to look ahead and consider how we can build our digital health services and technologies to transform the practice of medicine and our health economy.
Here is the link:
As I listened, feeling grateful to my university teachers that I had the background to understand most of what was discussed, it struck me just how new much of what was being discussed actually was. While the domain experts may have been all over most of what was being discussed five years ago a decade ago most was just a twinkle of scientific hope.
This inevitably made me reflect on other technology changes we have seen in the last decade – remember the iPhone is still to turn 10 – and wonder just what the next 10 to 20 years will bring.
In parallel with this I have been keeping an eye on the HIMSS conference which was happening last week in the USA. Now I know the IBM CEO is talking her own book but it is pretty clear there is something real happening here.
Big Blue also announced value-based care solutions, Watson Health consulting services and a partnership with Atrius Health.
By Tom Sullivan
February 20, 2017 11:27 AM
ORLANDO — IBM chief executive Ginni Rometty on Monday said that cognitive computing technologies could usher in a golden era for personalized and precision medicine.
“We’re in a moment when we can actually transform pieces of healthcare. It’s within our power,” Rometty said here during the HIMSS17 keynote. “This era that will play out in front of us can change the world for the better.”
Big Blue also announced value-based care solutions, new Watson Health consulting services, and an agreement with Atrius Health to integrate cognitive capabilities into EHRs to deliver insights clinicians can use when treating patients at the point of care.
Rometty pointed to work already underway at Memorial Sloan Kettering and Cleveland Clinic to advance cognitive computing, though she did not name former partner MD Anderson, after a report surfaced yesterday in Forbes that the cancer center put its Watson oncology work on hold and, instead, will go out to the marketplace for competitive bids.
Lots more here:
This useful review of the AI area also appeared a few days ago.
Digital Health News reporter Laura Stevens explores how the brave new world of artificial intelligence is now being applied to healthcare, the huge potential opportunities and the new ethical and privacy challenges it raises.
20 February 2017
The unsettling yet fascinating power of artificial intelligence is a favourite dystopian trope for film-makers. From robots taking over the world to falling in love with an operating system, the future seems to be disconcertingly jam packed full with this particular technology.
However, stepping back from Hollywood into the world of the NHS, how much do these fantastic scenarios relate to healthcare reality?
Firstly, while it may not be a mature technology, AI is definitely not a tool from the future; it’s in use right now by allowing researchers to compute vast amounts of data and replicating clinicians’ professional opinions.
The computational power of AI has been demonstrated in dermatology, cardiology and cancer research, where its analysis has provided an unbiased support to clinical opinion.
Secondly, there are huge challenges facing the introduction of this cutting edge technology into the health service, from creaky IT infrastructure, unverified data and patient data confidentiality.
Lots more here:
Now I am not smart enough to know what is next, but it seems pretty clear that Genomics, AI and so on are going to have a major impact – and likely sooner ( less than 5 years) rather than later I believe. Thus it would be very valuable if the ADHA released its ‘Impact Of New and Emerging Technology Scan’ for discussion well before the Digital Health Strategy is released as we need as much input as possible to make sure we cover as many bases as possible as the way forward is considered. I seriously doubt the ADHA boffins know it all in this domain!
One can only hope that a step like this might actually lift the present low confidence expressed by readers of this blog in the overall process as reflected by last week’s poll.
Posted by Dr David More MB PhD FACHI at Sunday, February 26, 2017